HealthUnlocked

Redirect Notice

Looks like you clickedhttps://www.urotoday.com/conference-highlights/aua-2023/aua-2023-prostate-cancer/144012-aua-2023-embark-a-phase-3-randomized-study-of-enzalutamide-or-placebo-plus-leuprolide-acetate-and-enzalutamide-monotherapy-in-high-risk-biochemically-recurrent-prostate-cancer.html

If you do not want to visit that page, you can close this browser tab.